搜索临床试验以：PPI-1019（亚太地区）
总计3461个结果
-
Axovant Sciences Ltd.完全的
-
Nanfang Hospital of Southern Medical UniversityBeijing Ditan Hospital; Beijing 302 Hospital; First Affiliated Hospital, Sun Yat-Sen University; Beijing Shijitan Hospital, Capital Medical University 和其他合作者撤销
-
Abbott Medical DevicesCardiovascular Research Foundation, New York完全的
-
Northwestern UniversityAmerican Cancer Society, Inc.完全的
-
GGZ CentraalUniversity Medical Center Groningen; Maastricht University终止
-
Kerckhoff Heart CenterInstitute of Cardiology, Warsaw, Poland; University of Giessen; University Hospital Erlangen完全的
-
Idorsia Pharmaceuticals Ltd.完全的
-
University Hospital, Basel, SwitzerlandEurostars; Preventicus GmbH; Manufacture Modules Technologies SA; GETEMED GmbH完全的
-
Medical University of Silesia完全的
-
Biosensors Europe SABiosensors Interventional Technologies Pte Ltd完全的
-
Andrew Weeks MD MRCOGNational Institute for Health Research, United Kingdom; Liverpool Women's NHS Foundation Trust完全的
-
Ralf Degenhardt, PhDB. Braun Melsungen AG完全的
-
Meshalkin Research Institute of Pathology of CirculationMedtronic Bakken Research Center完全的
-
Corvus Pharmaceuticals, Inc.终止新冠肺炎美国, 哥伦比亚, 西班牙, 加拿大, 秘鲁, 巴西, 意大利, 阿根廷, 智利, 德国, 墨西哥, 乌克兰
-
Athira PharmaAlturas Analytics, Inc.; Labcorp Drug Development Inc完全的
-
University of WashingtonJanssen Pharmaceuticals主动，不招人
-
National Cancer Institute (NCI)M.D. Anderson Cancer Center终止复发性成人急性淋巴细胞白血病 | 成人 B 型急性淋巴细胞白血病 | 成人 B 型急性淋巴细胞白血病伴 t(9;22)(q34;q11.2); BCR-ABL1美国
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Abiomed Inc.完全的接受高风险 PCI 的患者。美国, 荷兰
-
Beijing Anzhen HospitalHeart Health Research Center招聘中
-
University of AlbertaAlberta Innovates Health Solutions; Institute of Health Economics, Canada招聘中
-
Nacuity Pharmaceuticals, Inc.Foundation Fighting Blindness主动，不招人